Values as of: 2025-05-02
ETF | Mid-Cap Blend | NYSE Arca
Last Closing
USD 26.21Change
+0.60 (+2.34)%Market Cap
USD 2.64BVolume
1.16MAnalyst Target
N/A
N/A
Verdict
The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Mid-Cap Total Stock Market Index. The fund invests at least 90% of net assets in stocks that are included in the index. The index includes the mid-cap portion of the Dow Jones U.S. Total Stock Market Index actually available to investors in the marketplace. The Dow Jones U.S. Mid-Cap Total Stock Market Index includes the components ranked 501-1000 by full market capitalization. The index is a float-adjusted market capitalization weighted index.
Company Website : www.csimfunds.com.
Currency: USD
Country : USA
Inception Date: 13/01/2011
Primary Benchmark: DJ US TSM Mid Cap TR USD
Primary Index: S&P 500 TR USD
Gross Expense Ratio: 0.07%
Management Expense Ratio: 0.05 %
N/A
N/A
| Symbol | Company Name | Allocation |
|---|---|---|
| 3672:TSE | AltPlus Inc | 0.63 % |
| FMS | Fresenius Medical Care Corporation | 0.48 % |
N/A
N/A
| Symbol | Name | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | 0.07 % |
-0.13 (-0.22%) |
USD 83.09B |
| IWR | iShares Russell Mid-Cap ETF | 0.19 % |
-0.17 (-0.20%) |
USD 36.82B |
| MDY | SPDR® S&P MIDCAP 400 ETF Trus.. | 0.24 % |
-1.02 (-0.19%) |
USD 20.27B |
| VXF | Vanguard Extended Market Index.. | 0.07 % |
-0.57 (-0.32%) |
USD 18.55B |
| SPMD | SPDR Russell Small Cap Complet.. | 0.06 % |
-0.08 (-0.16%) |
USD 11.19B |
| XMHQ | Invesco S&P MidCap Quality ETF | 0.25 % |
+0.02 (+0.02%) |
USD 4.90B |
| JHMM | John Hancock Multifactor Mid C.. | 0.44 % |
-0.12 (-0.21%) |
USD 3.62B |
| IVOO | Vanguard S&P Mid-Cap 400 Index.. | 0.15 % |
-0.16 (-0.16%) |
USD 2.34B |
| FSMD | Fidelity Small-Mid Factor | 0.00 % |
-0.12 (-0.31%) |
USD 1.24B |
| EQAL | Invesco Russell 1000 Equal Wei.. | 0.20 % |
-0.23 (-0.49%) |
USD 0.58B |
N/A
| Market Performance vs. Industry/Classification (Mid-Cap Blend) | Market Performance vs. Exchange (NYSE Arca) | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -5.41% | 39% | F | 34% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -5.41% | 39% | F | 32% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | 0.77% | 39% | F | 48% | F | ||
| Dividend Return | 2.21% | 94% | A | 42% | F | ||
| Total Return | 2.98% | 39% | F | 42% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | 68.73% | 5% | F | 64% | D | ||
| Dividend Return | 24.57% | 100% | F | 62% | D | ||
| Total Return | 93.30% | 37% | F | 66% | D+ | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 7.77% | 26% | F | 63% | D | ||
| Dividend Return | 9.42% | 37% | F | 61% | D- | ||
| Total Return | 1.65% | 100% | F | 39% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 19.57% | 47% | F | 52% | F | ||
| Risk Adjusted Return | 48.15% | 37% | F | 64% | D | ||
| Market Capitalization | 2.64B | N/A | N/A | N/A | N/A | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
